Protective effects of ghrelin on ischemic/reperfusion injury of isolated hearts in rats

Chinese Pharmacological Bulletin

Volumn 19, Issue 11, 2003, Pages 1269-1273

  Ren, Yong Sheng ^a,d   Liu, Xiu Hua ^c   Yang, Jing Hui ^a   Geng, Bin ^b   Tang, Chao Shu ^a,c   Li, Ju Xiang ^b   Chang, Lin ^a,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Ghrelin; Hearts; Protective; Receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; DRUG RECEPTOR; GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE; LACTATE DEHYDROGENASE; MALONALDEHYDE; MYOGLOBIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HEART; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; NONHUMAN; RAT; REPERFUSION INJURY; SARCOPLASMIC RETICULUM;

EID: 0346494269     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bodart V, Febbraio M, Demers A et al. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res, 2002; 90(8):844-9
2. Matsumura K, Tsuchihashi T, Fujii K et al. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension, 2002; 40(5):694-9
3. Nagaya N, Uematsu M, Kojima M et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation, 2001; 104(12):1430-5
4. Chang L, Du JB, Gao LR et al. Effect of ghrelin on septic shock in rats. Acta Pharmacol Sin, 2003; 24(1):45-9
5. Merin RG. The isolated heart preparation. Br J Anaest, 1988; 60(8):28-34
6. Webster KW, Discher DJ, Bishopric NH et al. Cardioprotection in in vitro model of hypoxic preconditioning. J Mol Cell Cardiol, 1995; 27(1):453-8
7. Elz JS, Nayler WG. Quantification of calcium paradox in neonatal rat hearts. Am J Physiol, 1987; 253(6)H1358-64
8. Askawa T, Matashushita S. Thiobarbituric acid test for detecting lipid peroxide. Lipids, 1979; 14(5):401-6
9. Hull-Ryde EA, Lewis WR, Veronee CD et al. Simple step gradient elution of the major high energy compounds and their catobolities in cardiac muscle using high performance liquid chromatography. J Chromatogr, 1986; 377(25):165-74
10. Tang CS, Liu MS. Initial externalization followed by internalization of β-adrenergic receptors in rat heart during sepsis. Am J Physiol, 1996; 270(39):R254-63
11. Jones LR, Beseech HR. Isolation of canine cardiac sarcolemmal vesicles. Meth Pharmacol, 1984; 5(1):1-12
12. 2+-ATPase activities of heart sarcolem microsomes and mitochondria. J Biochem, 1977; 82(6):1731-9
13. 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest, 2001; 24(3):RC7-9
14. Gnanapavan S, Kola B, Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab, 2002; 87(6):2988
15. Papotti M, Ghe C, Cassoni P et al. Growth hormone secretagogue bidning sites in peripheral human tissues. J Clinical Endocrinol Met, 2000;85(10):3803-7
16. Baldanzi G, Filigheddu N, Cutrupi S et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol, 2002;159 (6):1029-37
17. Katugampola SD, Kuc RE, Maguire JJ et al. G-protein-coupled receptors in human atherosclerosis: Comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors. Clin Sci (Lond), 2002; 103(Suppl 48):171-5
18. Bodart V, Febbraio M, Demers A et al. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res, 2002 90(8):844-9